Richard Drake to Mass Spectrometry
This is a "connection" page, showing publications Richard Drake has written about Mass Spectrometry.
Connection Strength
2.246
-
Mass Spectrometry Imaging in Cancer Research: Future Perspectives. Adv Cancer Res. 2017; 134:283-290.
Score: 0.496
-
Pathogen identifi cation using mass spectrometry in the clinical microbiology laboratory. J Mass Spectrom. 2011 Dec; 46(12):1.
Score: 0.349
-
Applications and continued evolution of glycan imaging mass spectrometry. Mass Spectrom Rev. 2023 03; 42(2):674-705.
Score: 0.171
-
Mass Spectrometry Imaging of Fibroblasts: Promise and Challenge. Expert Rev Proteomics. 2021 06; 18(6):423-436.
Score: 0.170
-
Multiplexed Imaging Mass Spectrometry of Histological Staining, N-Glycan and Extracellular Matrix from One Tissue Section: A Tool for Fibrosis Research. Methods Mol Biol. 2021; 2350:313-329.
Score: 0.164
-
Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues. Mol Cell Proteomics. 2021; 20:100012.
Score: 0.163
-
A Rapid Array-Based Approach to N-Glycan Profiling of Cultured Cells. J Proteome Res. 2019 10 04; 18(10):3630-3639.
Score: 0.150
-
Glycosylation and its implications in breast cancer. Expert Rev Proteomics. 2019 08; 16(8):665-680.
Score: 0.148
-
Preface. Adv Cancer Res. 2017; 134:xiii-xiv.
Score: 0.124
-
Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells. Oncol Rep. 2005 Nov; 14(5):1323-30.
Score: 0.057
-
Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann Surg Oncol. 2004 Oct; 11(10):907-14.
Score: 0.053
-
Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. Mol Cell Proteomics. 2022 05; 21(5):100225.
Score: 0.045
-
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nat Commun. 2016 06 28; 7:11906.
Score: 0.030
-
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer. Oncotarget. 2015 Dec 22; 6(41):43743-58.
Score: 0.029
-
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics. 2013 Oct; 12(10):2935-51.
Score: 0.024
-
Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. J Proteome Res. 2012 Apr 06; 11(4):2386-96.
Score: 0.022
-
Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization. Mol Immunol. 2012 Apr; 50(4):253-61.
Score: 0.022
-
Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis. Biochemistry. 2006 Feb 21; 45(7):2322-32.
Score: 0.015
-
Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics. 2004 Mar; 4(3):826-38.
Score: 0.013